[go: up one dir, main page]

EP3621584A1 - Procédés pour réduire la transpiration et/ou les odeurs corporelles en utilisant des composés phosphonates avec des groupes amino et/ou hydroxyle - Google Patents

Procédés pour réduire la transpiration et/ou les odeurs corporelles en utilisant des composés phosphonates avec des groupes amino et/ou hydroxyle

Info

Publication number
EP3621584A1
EP3621584A1 EP18722050.4A EP18722050A EP3621584A1 EP 3621584 A1 EP3621584 A1 EP 3621584A1 EP 18722050 A EP18722050 A EP 18722050A EP 3621584 A1 EP3621584 A1 EP 3621584A1
Authority
EP
European Patent Office
Prior art keywords
antiperspirant
group
aluminum
cosmetic agent
cosmetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP18722050.4A
Other languages
German (de)
English (en)
Inventor
Bernhard Banowski
Marcus Claas
Detlef Keller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Publication of EP3621584A1 publication Critical patent/EP3621584A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A61K8/0229—Sticks

Definitions

  • the present invention relates to a method of reducing transpiration of the body and / or reducing body odor caused by transpiration, in which an antiperspirant cosmetic agent (M1) containing phosphonate compounds having amine and / or hydroxyl groups is applied to the human skin and remains for at least 1 hour at the application site.
  • This antiperspirant (M1) contains at most 1% by weight of antiperspirant aluminum and / or aluminum-zirconium salts.
  • the use of the phosphonate compound with amine and / or hydroxyl groups in the process according to the invention leads to an antiperspirant effect or to a reduction in body odor caused by perspiration.
  • the present invention relates to a packaging unit (kit-of-parts), which in a first container (C1) at least one phosphonate compound with amine and / or hydroxyl groups and at most 1 wt .-% antiperspirant salts and in a second container (C2) comprises at least one antiperspirant compound.
  • kit-of-parts which in a first container (C1) at least one phosphonate compound with amine and / or hydroxyl groups and at most 1 wt .-% antiperspirant salts and in a second container (C2) comprises at least one antiperspirant compound.
  • the present invention relates to the use of at least one phosphonate compound having amine and / or hydroxyl groups for reducing the transpiration of the body and / or for reducing the body odor caused by perspiration.
  • washing, cleansing and caring for one's own body is a basic human need, and modern industry is constantly trying to meet these needs in many ways. Especially important for daily hygiene is the permanent elimination or at least reduction of body odor and underarm wetness.
  • Numerous specific deodorant or antiperspirant personal care products are known in the art which have been developed for use in body regions having a high density of sweat glands, especially in the underarm area. These are packaged in a wide variety of dosage forms, for example as powder, in stick form, as aerosol spray, pump spray, liquid and gel-like roll-on application, cream, gel and as impregnated flexible substrates (handkerchiefs).
  • the cosmetic antiperspirants used to reduce transpiration in prior art processes contain at least one antiperspirant compound, in particular in the form of halides and / or hydroxyhalides of aluminum and / or zirconium.
  • These antiperspirant compounds reduce sweat secretion of the body by temporarily narrowing and / or obstructing the ducts of the sweat glands, so that the amount of sweat can be reduced by about 20 to 60 percent.
  • they prevent because of their antimicrobial effect the degradation of initially odorless sweat to malodorous compounds and thus the formation of body odor.
  • the halides and / or hydroxy halides of aluminum and / or zirconium contained in the agents used can, in conjunction with the acidic pH of these agents, cause unpleasant skin reactions in some users.
  • the use of the aforementioned antiperspirant compounds can lead to staining on clothing.
  • the present invention has for its object to provide a method for reducing the transpiration of the body and / or to reduce the induced by the perspiration body odor, which avoids the disadvantages of the prior art or at least mitigates and which to a reliable reduction of underarm wetness and / or body odor with good skin compatibility leads.
  • the present invention thus relates to a cosmetic method for reducing the transpiration of the body and / or for reducing the body odor caused by transpiration, in which an antiperspirant cosmetic agent (M1) is applied to the human skin and remains at the site of application for at least 1 hour in which the antiperspirant cosmetic agent (M1) is administered in a cosmetically acceptable vehicle, based on the total weight of the cosmetic product (M1), a) at least one phosphonate compound which contains at least one tertiary amine group and / or at least one secondary amine group and / or at least one primary amine group and / or at least one hydroxyl group, and
  • b) contains at most 1 wt .-% of antiperspirant aluminum and / or aluminum zirconium salts.
  • cosmetic agents which contain at least one phosphonate compound with at least one amine and / or hydroxyl group
  • an excellent reduction of sweat, in particular axillary sweat is achieved without skin irritation occur.
  • the use of the at least one phosphonate compound also a reduced formation of body odor is observed.
  • the use of extremely small amounts or in the absence of antiperspirant halides and / or hydroxy halides of aluminum and / or zirconium an effective reduction of armpit sweat and / or body odor is ensured.
  • these compounds can be incorporated without problems into existing formulations and do not lead to negative interactions with the other ingredients of the cosmetic products, so that a high storage stability is achieved.
  • antiperspirant is understood according to the invention to reduce or reduce the transpiration of the eccrine sweat glands of the body.
  • aluminum and / or aluminum-zirconium salts in the context of the present invention, in particular chlorides, bromides and iodides of aluminum and / or zirconium and compounds of the formulas Al (OH) y X and Zr (OH) z X, where X in the abovementioned formulas is a halide ion.
  • phosphonate compound is understood to mean salts of organic compounds of phosphoric acid which have the general formula R-PO- (OX + ) 2 X + stands for a cation, for example H + , the radical R for an organic
  • the radical R can also contain other phosphonate or phosphonate groups, but the term "phosphonate compound” according to the present invention does not include any of the following groups: Phosphoric acid esters, in particular esters of phosphoric acid with organic radicals, the formula R-0-PO- (OX + ) to understand 2.
  • fatty acids as used in the context of the present invention means aliphatic carboxylic acids which have unbranched or branched carbon radicals having from 4 to 40 carbon atoms fatty acids used can be both naturally occurring and synthetically produced fatty acids. Furthermore, the fatty acids may be monounsaturated or polyunsaturated.
  • wt .-% relates in the present case, unless stated otherwise, to the total weight of the antiperspirant cosmetic agents (M1) used according to the invention without any propellant present.
  • the antiperspirant cosmetic agent (M1) is advantageously used to reduce transpiration in the armpit and / or to reduce underarm odor.
  • Preferred methods according to the invention are therefore characterized in that the antiperspirant cosmetic agent (M1) is applied to the skin of the armpit.
  • the antiperspirant cosmetic agents (M1) used according to the invention comprise the at least one phosphonate compound having at least one amine and / or hydroxyl group in a cosmetic carrier.
  • this carrier is preferably anhydrous, aqueous, alcoholic or aqueous-alcoholic. In the case of powder-containing suspensions, the use of anhydrous carrier has proved to be advantageous.
  • An anhydrous carrier is understood according to the invention to mean a carrier which contains less than 10% by weight, based on the total weight of the antiperspirant cosmetic agent (M1), of free water.
  • free water is understood to mean water which is different from water of crystallization, water of hydration or similar molecularly bound water of the constituents used.
  • the cosmetic carrier of the antiperspirant cosmetic agent (M1) used in the present invention preferably contains free water in a total amount of less than 8.0% by weight, preferably less than 5.0% by weight, more preferably less than 3.0 % By weight, even more preferably less than 1.0% by weight, in particular 0% by weight, based on the total weight of the antiperspirant cosmetic agent (M1).
  • Anhydrous carriers preferably contain a liquid at 20 ° C and 1 .013 hPa liquid cosmetic oil. These are understood to mean oils which are suitable for cosmetic use and which can not be mixed with water in all amounts, which are neither fragrances nor essential oils.
  • the at least one liquid cosmetic oil is preferably selected from the group of (i) volatile silicone oils, in particular volatile cyclic and linear silicone oils; (ii) volatile non-silicone oils, especially liquid paraffin oils, isoparaffin oils, ester oils and organic alcohols; (iii) nonvolatile silicone oils; (iv) non-volatile non-silicone oils; and (v) their mixtures.
  • volatile oil refers to oils which at 20 ° C and an ambient pressure of 1 .013 hPa a vapor pressure of 2.66 Pa to 40,000 Pa (0.02 to 300 mm Hg), preferably from 10 to 12,000 Pa (0.1 to 90 mm Hg), more preferably from 13 to 3,000 Pa (0.1 to 23 mm Hg), in particular from 15 to 500 Pa (0.1 to 4 mm Hg) ,
  • nonvolatile oils in the context of the present invention means oils which have a vapor pressure of less than 2.66 Pa (0.02 mm Hg) at 20 ° C. and an ambient pressure of 1.103 hPa.
  • the carrier used is a non-volatile silicone oil and / or a nonvolatile non-silicone oil to mask insoluble constituents, such as talc, phosphonate compounds or skin-dried ingredients.
  • Particularly preferred according to the invention is the use of mixtures of nonvolatile and volatile cosmetic oils, since in this way parameters such as skin feel, visibility of the residue and stability of the antiperspirant cosmetic agent (M1) used according to the invention are adjusted and the agent is thus better adapted to the needs of the consumer can.
  • the cosmetic oil which is liquid at 20 ° C. and 1013 hPa is preferably used in a total amount of from 1.0 to 98% by weight, preferably from 2.0 to 85% by weight, preferably from 4.0 to 75% by weight. , more preferably from 6.0 to 70 wt .-%, still more preferably from 8.0 to 60 wt .-%, in particular from 8.0 to 20 wt .-%, based on the total weight of the antiperspirant cosmetic agent (M1 ).
  • an aqueous carrier contains at least 10% by weight, based on the total weight of the antiperspirant cosmetic agent (M1), of free water.
  • the carrier contains free water in a total amount of 15 to 98 wt .-%, preferably from 30 to 70 wt .-%, in particular from 40 to 60 wt .-%, based on the total weight of the antiperspirant cosmetic agent (M1).
  • alcoholic carriers contain at least 1.0% by weight, based on the total weight of the antiperspirant cosmetic agent (M1), of a C 1 -C 4 alcohol and / or of a C 2 -C 6 alcohol with at least one hydroxyl group.
  • M1 antiperspirant cosmetic agent
  • C 1 -C 4 alcohol a C 1 -C 4 alcohol
  • C 2 -C 6 alcohol with at least one hydroxyl group.
  • These include, for example, ethanol, ethylene glycol, isopropanol, 1, 2-propylene glycol, 1, 3-propylene glycol, glycerol, n-butanol, 1, 3-butylene glycol and mixtures thereof.
  • Ethanol is particularly preferably used as the alcoholic carrier.
  • a preferred alcoholic carrier contains ethanol in a total amount of 1, 0 to 98 wt .-%, preferably from 5.0 to 70 wt .-%, preferably from 7.0 to 50 wt .-%, in particular from 10 to 30 wt .-%, based on the total weight of the antiperspirant cosmetic agent (M1).
  • aqueous-alcoholic carriers are aqueous carriers which, in addition to water, additionally contain at least 1.0% by weight, based on the total weight of the antiperspirant cosmetic agent (M1), of a C 1 -C 4 alcohol and / or of a C 2 -C 4 alcohol -C6 alcohol containing at least one hydroxy group to understand.
  • M1 antiperspirant cosmetic agent
  • the antiperspirant and / or odor-inhibiting effect achieved by means of the method according to the invention is preferably achieved exclusively by using the at least one phosphonate compound. It is therefore within the scope of the present invention advantageous if the cosmetic agent (M1) contains 0 wt .-%, based on the total weight of the cosmetic agent (M1), of antiperspirant aluminum and / or aluminum zirconium salts. Therefore, cosmetic agents (M1) used particularly preferably according to the invention contain no antiperspirant salts of aluminum and / or aluminum zirconium. In particular, none of the following antiperspirant salts of aluminum and / or aluminum zirconium are preferably included:
  • water-soluble astringent inorganic salts of aluminum especially aluminum chlorohydrate, aluminum sesquichlorohydrate, aluminum dichlorohydrate, aluminum hydroxide, potassium aluminum sulfate, aluminum bromohydrate, aluminum chloride, aluminum sulfate;
  • water-soluble astringent organic salts of aluminum in particular aluminum chlorohydrex-propylene glycol, aluminum chlorohydrex-polyethylene glycol, aluminum-propylene glycol complexes, aluminum sesquichlorohydrex-propylene glycol, aluminum sesqui-chlorohydrex-polyethylene glycol, aluminum-propylene glycol-dichlorohydrex, aluminum-poly-ethylene glycol dichlorohydrex, aluminum undecylenoyl collagen amino acid Sodium aluminum lactate, sodium aluminum chlorhydroxylactate, aluminum lipoamino acids, aluminum lactate, aluminum chlorohydroxyallantoinate, sodium aluminum chlorohydroxylactate;
  • water-soluble astringent inorganic aluminum-zirconium salts in particular aluminum zirconium trichlorohydrate, aluminum zirconium tetrachlorohydrate, aluminum zirconium pentachlorohydrate, aluminum zirconium octachlorohydrate;
  • water-soluble astringent organic aluminum-zirconium salts especially aluminum zirconium-propylene glycol complexes, aluminum zirconium trichlorohydrex glycine, aluminum zirconium tetrachlorohydrex glycine, aluminum zirconium pentachlorohydrex glycine, aluminum zirconium octachlorohydrex glycine; such as
  • phosphonate compounds having at least one tertiary or at least one secondary amine group are used.
  • Preferred processes according to the invention are therefore characterized in that the at least one phosphonate compound which contains at least one tertiary amine group or at least one secondary amine group has the formula (I)
  • X + and Y + each independently, represent a mono- or polyvalent cation from the group of alkali metals, alkaline earth metals, transition metals or organic cations, ammonium or hydrogen.
  • the term "organic cations" is to be understood as meaning cationic compounds which contain at least one carbon atom.
  • the meaning of X + and Y + in the radicals R, R and R 3 here corresponds to the meaning of X + and Y + in the formula (I)
  • the attachment of the groups R, R and R 3 to the respective nitrogen atom is indicated by the symbol *
  • the use of these phosphonate compounds of the formula (I) in the process according to the invention leads to a good antiperspirant effect, but without Storage stability of the cosmetic agents adversely affect or cause skin irritation.
  • the organic cation is selected from the group of basic amino acids, choline, compounds of the formula N + (Rs) 4, wherein Rs is for linear or branched C 2 -C 10 -alkyl groups which are optionally substituted by at least one hydroxyl group, imidazolium compounds, pyridinium compounds, pyrrolidinium compounds and sulfonium compounds.
  • Basic amino acids have at least one proton acceptor in the side chain. Such amino acids are, for example, arginine, histidine and lysine.
  • Compounds of the formula N + (Rs) 4 are understood as meaning protonated alkylamines and alkanolamines.
  • alkylamines are monoalkyl, dialkyl and trialkylamines, such as diethyl and triethylamine, diisopropylamine and isopropylamine.
  • Alkanolamines or amino alcohols have both an amino and a hydroxy group.
  • the radical Rs in the formula N + (Rs) 4 therefore contains at least one OH group.
  • Alkanolamines which are suitable in the context of the present invention are, for example, choline, which is also known by the name [(2-hydroxyethyl) trimethylammonium and has the formula HO-CH 2 -CH 2 -N + (CH 3) 3.
  • alkanolamines are selected from the group of 2-aminoethan-1-ol (monoethanolamine), 3-aminopropan-1-ol, 4-aminobutan-1-ol, 5-aminopentan-1-ol, 1-aminopropane-2 ol (monoisopropanolamine), 1-aminobutan-2-ol, 1-aminopentan-2-ol, 1-aminopentan-3-ol, 1-aminopentan-4-ol, 2-amino-2-methyl-propanol, 2 -Amino-2-methylbutanol, 3-amino-2-methylpropan-1-ol, 1-amino-2-methylpropan-2-ol, 3-aminopropane-1,2-diol, 2-amino-2-methylpropane-1 , 3-diol, 2-amino-2-ethyl-1, 3-propanediol, N, N-dimethyl-ethanolamine, triethanolamine, di
  • the imidazolium compounds (formula (III)), pyridinium compounds (formula (IV)), pyrrolidinium compounds (formula (V)) and sulfonium compounds (formula (VI)) which can be used in the context of the present invention preferably have the following formulas (III) to (VI ), in which the radical R6 is in each case hydrogen, OH or a linear or branched C 2 -C 10 -alkyl group which is optionally substituted by at least one hydroxyl group
  • the mono- or polyvalent cation from the group of the alkali, alkaline earth and transition metals is preferably selected from certain representatives of these metals.
  • Preferred processes according to the invention of this embodiment are therefore characterized in that the mono- or polyvalent cation is selected from the group of alkali metals, alkaline earth metals and transition metals
  • a and b are each the integer 2
  • This compound has the following structural formula and is also referred to as aminotrimethylene phosphonate (ATMP)
  • this phosphonate compound leads to a significant antiperspirant effect, so that the use of further antiperspirant compounds, which are perceived by the consumer as critical or cause skin irritation, can be dispensed with.
  • this phosphonate compound can be incorporated stably into already existing cosmetic formulations and does not lead to negative interactions with other ingredients or to a reduced storage stability.
  • These compounds have the following structural formula and also lead to an excellent antiperspirant effect, but without adversely affecting the storage stability of the cosmetic products (M1) or lead to undesirable skin irritation.
  • a and b are each the integer 1
  • ATMP aminotrimethylene phosphonate
  • Ethylenediaminetetra (methylenephosphonate) (EDTMP) and / or the
  • ATMP aminotrimethylene phosphonate
  • ETMP ethylenediaminetetra (methylene phosphonate)
  • Diethylenetriaminepenta (methylenephosphonate) (DTPMP) and / or compounds having the above structural formula may also be intended to employ phosphonate compounds termed imidodiphosphate. It may therefore also be advantageous according to the invention if in the formula (I) a and b are each the integer 0, R is hydrogen and X + and Y + , each independently of one another, are hydrogen or Na + . These compounds have the following structural formula and also lead to an excellent antiperspirant effect, but without adversely affecting the storage stability of the cosmetic products (M1) or lead to undesirable skin irritation.
  • phosphonate compounds having at least one hydroxyl group are used.
  • Preferred processes according to the invention are therefore characterized in that the at least one phosphonate compound which contains at least one hydroxyl group has the formula (II)
  • R4 is a linear or branched, saturated or unsaturated C 1 -C 30 -alkyl group, d and e, each independently of one another, are integers from 0 to 10, preferably from 0 to 6, preferably from 0 to 4, in particular 0 or 1 stand, X + and Y + , each independently, represent a mono- or polyvalent cation from the group of alkali metals, alkaline earth metals, transition metals or organic cations, ammonium or hydrogen.
  • organic cations is to be understood as meaning cationic compounds which contain at least one carbon atom.
  • the use of these phosphonate compounds of the formula (II) in the process according to the invention leads to a good antiperspirant effect, without negatively influencing the storage stability of the cosmetic agents or cause skin irritation.
  • the organic cation is selected from the group of basic amino acids, choline, compounds of formula N + (R) 4, wherein Rs is linear or branched C2-Cio-alkyl groups which are optionally substituted with at least one Hydroxyl group are substituted, imidazolium compounds, pyridinium compounds, pyrrolidinium compounds and sulfonium compounds.
  • Basic amino acids have at least one proton acceptor in the side chain. Such amino acids are, for example, arginine, histidine and lysine.
  • Compounds of the formula N + (Rs) 4 are understood as meaning protonated alkylamines and alkanolamines.
  • alkylamines are monoalkyl, dialkyl and trialkylamines, such as diethyl and triethylamine, diisopropylamine and isopropylamine.
  • Alkanolamines or amino alcohols have both an amino and a hydroxy group.
  • the radical Rs in the formula N + (Rs) 4 therefore contains at least one OH group.
  • Alkanolamines which are suitable in the context of the present invention are, for example, choline, which is also known by the name [(2-hydroxyethyl) trimethylammonium and has the formula HO-CH 2 -CH 2 -N + (CH 3) 3.
  • alkanolamines are selected from the group of 2-aminoethane-1-ol (monoethanolamine), 3-aminopropan-1-ol, 4-aminobutan-1-ol, 5-aminopentan-1-ol, 1-aminopropane-2 ol (monoisopropanolamine), 1-aminobutan-2-ol, 1-aminopentan-2-ol, 1-aminopentan-3-ol, 1-aminopentan-4-ol, 2-amino-2-methyl-propanol, 2 -Amino-2-methylbutanol, 3-amino-2-methylpropan-1-ol, 1-amino-2-methylpropan-2-ol, 3-aminopropane-1, 2-diol, 2-amino-2-methylpropane-1 , 3-diol, 2-amino-2-ethyl-1, 3-propanediol, N, N-dimethyl-ethanolamine, triethanolamine,
  • the imidazolium compounds (formula (III)), pyridinium compounds (formula (IV)), pyrrolidinium compounds (formula (V)) and sulfonium compounds (formula (VI)) which can be used in the context of the present invention preferably have the following formulas (III) to (VI ), in which the radical R6 is in each case hydrogen, OH or a linear or branched C 2 -C 10 -alkyl group which is optionally substituted by at least one hydroxyl group
  • the mono- or polyvalent cation from the group of the alkali, alkaline earth and transition metals is preferably selected from certain representatives of these metals.
  • Preferred processes according to the invention of this embodiment are therefore characterized in that the mono- or polyvalent cation is selected from the group of alkali metals, alkaline earth metals and transition metals
  • R4 is a Cn-alkyl group
  • d and e are each the integer 0 and X + and Y + , each independently of one another, are hydrogen or Na + .
  • This compound has the following structural formula and is also referred to as (1-hydroxy-1,1-dodecanediyl) bis (phosphonate)
  • this phosphonate compound leads to an excellent antiperspirant effect, so that the use of further antiperspirant compounds, which are perceived by the consumer as critical or cause skin irritation, can be dispensed with.
  • this phosphonate compound can be incorporated stably into already existing cosmetic formulations and does not lead to negative interactions with other ingredients or to a reduced storage stability.
  • the at least one phosphonate compound in the cosmetic agent (M1) in specific quantitative ranges.
  • Processes preferred according to the invention are therefore characterized in that the cosmetic agent (M1) contains at least one phosphonate compound a) in a total amount of from 0.1 to 40% by weight, preferably from 0.2 to 30% by weight, preferably from 1 , 0 to 25 wt .-%, in particular from 2.0 to 10 wt .-%, based on the total weight of the cosmetic product (M1).
  • the use of the at least one phosphonate compound, in particular of the abovementioned specific phosphonate compounds, in the abovementioned total amounts in the process according to the invention leads to an excellent reduction in perspiration and / or body odor triggered by transpiration. Furthermore, no skin irritation or storage instabilities occur when using the at least one phosphonate compound in the aforementioned amounts.
  • the quantities given above refer to the total amount of the mixture of phosphonate compounds.
  • the antiperspirant cosmetic agents (M1) used in the process according to the invention preferably have a certain pH. Within this range, a stable formulation of the antiperspirant cosmetic agents (M1) used according to the invention is possible without undesirable interactions between the ingredients occurring. Further, at these pH values, no skin irritation occurs when these agents are used. It is therefore advantageous if the cosmetic agent (M1) has a pH of from pH 2.5 to pH 9.0, preferably from pH 2.5 to pH 8.5, preferably from pH 2.5 to pH 8.0 , in particular from pH 3.0 to pH 7.0.
  • the desired pH can be adjusted by using acids and bases which are known to the person skilled in the art and are customary in antiperspirant cosmetic agents.
  • the antiperspirant cosmetic agent (M1) used in the method according to the invention may contain, in addition to the ingredients mentioned above, further substances.
  • the antiperspirant cosmetic agent (M1) additionally preferably contains at least one wide adjuvant selected from the group of (i) emulsifiers and / or surfactants; (ii) thickeners; (iii) chelating agents; (iv) deodorant agents; (v) polyethylene glycols; (vi) skin-cooling agents; (vii) pH adjusters; (viii) skin care ingredients, such as moisturizers, skin soothing substances, skin lightening substances, skin smoothing substances; (ix) waxing; (x) preservatives; (xi) plant extracts; (xii) absorbers; (xiii) perfume oils; and (xiv) their mixtures.
  • at least one wide adjuvant selected from the group of (i) emulsifiers and / or surfactants; (ii) thickeners; (iii) chelating agents; (iv) deodorant agents; (v) polyethylene glycols; (vi) skin-cooling agents; (vii) pH adjust
  • Emulsifiers and surfactants which are preferably suitable according to the invention are selected from anionic, cationic, nonionic, amphoteric, in particular ampholytic and zwitterionic emulsifiers and surfactants.
  • Surfactants are amphiphilic (bifunctional) compounds which consist of at least one hydrophobic and at least one hydrophilic moiety.
  • the hydrophobic residue is preferably a hydrocarbon chain of 8 to 28 carbon atoms, which may be saturated or unsaturated, linear or branched. Most preferably, this Cs-C28 alkyl chain is linear.
  • Emulsifiers and surfactants which can preferably be used in the context of the present invention are disclosed, for example, in the published patent application DE 10 2012 222 692 A1.
  • Substances which are selected from cellulose ethers, xanthan gum, sclerotium gum, succinoglucans, polygalactomannans, pectins, agar, carrageenan (carrageenan), tragacanth, gum arabic, karaya gum, tara gum are preferably used to thicken the antiperspirant cosmetic agents (M1) used according to the invention , Gellan, gelatin, propylene glycol alginate, alginic acids and their salts, polyvinylpyrrolidones, polyvinyl alcohols, polyacrylamides, physically (eg by pre-gelatinization) and / or chemically modified starches, acrylic acid-acrylate copolymers, acrylic acid-acrylamide copolymers, acrylic acid Vinylpyrrolidone copolymers, acrylic acid-vinylformamide copolymers and polyacrylates.
  • M1 antiperspirant cosmetic agents
  • Cellulose ethers such as carboxyalkylcelluloses, are particularly preferably used as thickening agents. Particularly preferred thickeners are furthermore selected from carbomers.
  • Carbomers are thickening crosslinked polymers of acrylic acid, methacrylic acid and their salts. The crosslinking can be effected by means of polyfunctional compounds such as polyalkylene ethers of polysaccharides or polyalcohols, for example sucrose allyl ether, pentaerythritol allyl ether, propylene allyl ether.
  • Preferred in the context of the present invention are homopolymers of acrylic acid or salts thereof which are crosslinked with a pentaerythritol allyl ether, a sucroseallyl ether or a propylene allyl ether.
  • a thickening agent which can be used in the context of the present invention is a copolymer of Cio-30-alkyl acrylate, acrylic acid, methacrylic acid and esters thereof, which is crosslinked with a sucrose allyl ether or a pentaerythritol allyl ether.
  • Thickener based on carbomers are products sold under the trade name Carbopol ® (BF Goodrich, Ohio, USA) available such as Carbopol 934, Carbopol 940, Carbopol 941, Carbopol 971, Carbopol 974, Carbopol EZ2, Carbopol ETD 2001, Carbopol ETD 2020, Carbopol ETD 2050, Carbopol ultrez 10, Carbopol ultrez 20, or Carbopol ultrez 21.
  • Carbopol ® BF Goodrich, Ohio, USA
  • lipophilic thickening agents can be used to thicken the antiperspirant cosmetic agents (M1) used according to the invention.
  • Preferred lipophilic thickeners according to the invention are selected from hydrophobized clay minerals, bentonites, hectorites, pyrogenic silicic acids and derivatives thereof.
  • the antiperspirant cosmetic agents (M1) used according to the invention may comprise at least one chelating agent, in a total amount of from 0.01 to 3.0% by weight, preferably from 0.02 to 1.0% by weight, in particular from 0 , 05 to 0.1 wt .-%, based on the total weight of the antiperspirant agent (M1) included.
  • preferred chelating agents are selected from the group of ⁇ -alaninediacetic acid, cyclodextrin, sodium, potassium, calcium disodium, ammonium and triethanolamine salts of ethylenediaminetetraacetic acid (EDTA), hydroxyethylethylenediaminetetraacetic acid (HEDTA) and their sodium salts, sodium salts of Nitrilotriacetic acid (NTA), diethylenetriaminepentaacetic acid, phytic acid, hydroxypropylcyclodextrin, methylcyclodextrin, diethylenetriaminepentaacetate- Pentasodium, pentasodium triphosphate, sodium dihydroxyethylglycinate, sodium phytate, sodium polydimethylglycinophenolsulphonate, tetrahydroxyethylethylenediamine, tetrahydroxypropylethylenediamine, tetrapotassium tetidronate, te
  • Tetrasodiumiminodisuccinate trisodium ethylenediamine disuccinate, tetrasodium N, N-bis (carboxymethyl) glutamate, tetrasodium DL-alanine-N, N-diacetate and desferrioxamine.
  • the deodorizing effect of the antiperspirant cosmetic agents (M1) used according to the invention can be further increased if additionally at least one deodorant active ingredient having antibacterial and / or bacteriostatic and / or enzyme inhibiting and / or odor-neutralizing and / or odor-absorbing action in a total amount of 0.0001 to 40 wt .-%, preferably from 0.2 to 20 wt .-%, preferably from 1 to 15 wt .-%, in particular from 1, 5 to 5.0 wt .-%, based on the total weight of the antiperspirant cosmetic By means of (M1), is included. If ethanol is used in the compositions according to the invention, this does not apply in the context of the present invention as a deodorant active ingredient, but as a constituent of the carrier.
  • Preferred antiperspirant cosmetic agents (M1) used in the present invention may further contain at least one water-soluble polyethylene glycol having 3 to 50 ethylene oxide units.
  • the antiperspirant cosmetic agents (M1) used according to the invention may further comprise at least one skin-cooling active agent.
  • Skin-cooling active ingredients suitable according to the invention are, for example, menthol, isopulegol and menthol derivatives, eg.
  • Preferred skin-cooling active ingredients are menthol, isopulegol, menthyl lactate, menthoxypropanediol, menthylpyrrolidonecarboxylic acid and 5-methyl-2- (1-methylethyl) cyclohexyl-N-ethyloxamate, and mixtures of these substances, in particular mixtures of menthol and menthyl lactate, menthol, menthol glycolate and menthyl lactate, menthol and menthoxypropanediol or menthol and isopulegol.
  • the pH adjusting agents used are preferably acids and / or alkalizing agents and / or buffers.
  • acids according to the invention preferably inorganic acids (such as hydrochloric acid, sulfuric acid or phosphoric acid) or organic acids (such as lactic acid, citric acid, tartaric acid or malic acid) are used.
  • Alkaliating agents which can be used according to the invention are preferably selected from the group which is formed from ammonia, basic amino acids, alkali metal hydroxides, alkaline earth metal hydroxides, carbonates and bicarbonates, alkanolamines, for example amino-2-methyl-1-propanol, monoethanolamine, Triethanolamine, diethanolamine and triisopropanolamine, alkali metal metasilicates, urea, morpholine, N-methylglucamine, imidazole.
  • the alkali metal ions used are preferably lithium, sodium, potassium, in particular sodium or potassium.
  • Suitable buffer systems in the context of the present invention are, in particular, carbonic bicarbonate buffers, carbonic acid / silicate buffers, acetic acid / acetate buffers, ammonia buffers, citric acid or citrate buffers, buffers based on tris (hydroxymethyl) aminomethane, buffers based on 4- (2-hydroxyethyl) -1-piperazineethanesulfonic acid, buffer based on 4- (2-hydroxyethyl) piperazine-1-propanesulfonic acid, buffer based on 2- (N-morpholino) ethanesulfonic acid and barbital acetate buffer.
  • the choice of the corresponding buffer system depends on the desired pH of the antiperspirant cosmetic agents (M1) used according to the invention. However, the at least one phosphonate compound used according to the invention does not fall under the abovementioned pH adjusting agents in the form of acids and buffer systems.
  • the antiperspirant cosmetic agents (M1) used according to the invention may contain at least one wax.
  • This term is understood to mean substances which are kneadable at 20 ° C. or solid to brittle, have a coarse to finely crystalline structure and are translucent to opaque in color but not glassy. Furthermore, these substances melt above 25 ° C without decomposition, are slightly above the melting point slightly liquid (less viscous), have a strong temperature-dependent consistency and solubility and are polishable under light pressure.
  • this wax is selected from the group of (i) fatty acid glycerol mono-, di- and triesters; (ii) Butyrospermum Parkii (Shea Butter); (iii) esters of saturated monohydric alcohols with saturated C12is monocarboxylic acids; (iv) linear, primary C 12-24 alkanols; (v) esters of a saturated monohydric C 16-6 o alkanol and a saturated C 8-36 monocarboxylic acid; (vi) glycerol triesters of saturated linear C 12-3o carboxylic acids which may be hydroxylated, such as glycerol esters of hydrogenated vegetable oils; (vii) natural vegetable waxes; (viii) animal waxes; (ix) synthetic waxes; and (x) their mixtures.
  • the wax is preferably used in a total amount of 0.01 to 60% by weight, preferably 3.0 to 40% by weight, preferably 5.0 to 30% by weight, more preferably 6.0 to 25% by weight. %, based on the total weight of the antiperspirant cosmetic agent (M1).
  • the antiperspirant cosmetic agent (M1) used according to the invention additionally contains at least one preservative.
  • Preservatives which are preferred according to the invention are formaldehyde releasers iodopropynyl-butylcarbamate, parabens, phenoxyethanol, ethanol, benzoic acid and its salts, dibromodipanobutane, 2-bromo-2-nitro-propane-1,3-diol, imidazolidinylurea, 5-chloro-2-methyl- 4-isothiazolin-3-one, 2-chloroacetamide, benzalkonium chloride, benzyl alcohol, salicylic acid and salicylates.
  • Preservatives which can be used in the present invention are cosmetic raw materials with preserving properties or raw materials which support or enhance the preservative action of the abovementioned preservatives.
  • the preservatives are preferably in a total amount of 0.01 to 10 wt .-%, preferably from 0.1 to 7.0 wt .-%, preferably from 0.2 to 5.0 wt .-%, in particular of 0, 3 to 2.0 wt .-%, based on the total weight of the antiperspirant cosmetic agent (M1) included.
  • Antiperspirant cosmetic agents (M1) used according to the invention may furthermore comprise at least one plant extract.
  • Plant extracts are usually prepared by extraction of the entire plant, but in some cases also exclusively from flowers and / or leaves and / or seeds and / or other parts of plants.
  • Especially preferred according to the invention are the extracts of aloe vera, green tea, witch hazel, bamboo, chamomile, marigold, pansy, peony, horse chestnut, sage, willow bark, cinnamon tree, chrysanthemums, oak bark, stinging nettle, hops, burdock root, horsetail, Hawthorn, Lime blossom, Almonds, Spruce needles, Sandalwood, Juniper, Coconut, Kiwi, Guava, Lime, Mango, Apricot, Wheat, Melon, Orange, Grapefruit, avocado, Rosemary, Birch, Beech shoots, Mallow, Meadowfoam, Yarrow, Quendel, Thyme, Melissa, hominy, marshmallow (Althaea), mallow (Malva sylvestris), violets, blackcurrant leaves, coltsfoot, Uberingerkraut, ginseng, ginger root and sweet potato.
  • algae extracts can also be used. These are preferably derived from green algae, brown algae, red algae or blue-green algae (cyanobacteria). Advantageous algae extracts come from kelp, blue-green algae, from the green alga Codium tomentosum as well as from the brown algae Fucus vesiculosus. A particularly preferred algae extract is derived from blue-green algae of the species Spirulina, which were cultured in a magnesium-enriched medium.
  • the at least one plant extract is preferably present in total amounts of 0.01 to 5.0 wt .-%, preferably from 0.1 to 2.0 wt .-%, in particular from 0.5 to 1, 0 wt .-%, each based on the total weight of the antiperspirant (M1).
  • the antiperspirant cosmetic agents (M1) contain at least one absorber.
  • Preferred absorbers are selected from silicates. These can also simultaneously support the theological properties of antiperspirants (M1).
  • the silicates which are particularly preferred according to the invention are, in particular, phyllosilicates and, among these, in particular montmorillonite, kaolinite, hit, beidellite, nontronite, saponite, hectorite, bentonite, smectite and talcum.
  • Further preferred absorbers are, for example, zeolites, zinc ricinoleate, cyclodextrins, certain metal oxides, such as alumina, and chlorophyll.
  • antiperspirant cosmetic agent (M1) used according to the invention is present as a water-in-oil emulsion. This may in particular be a sprayable water-in-oil emulsion, which can be sprayed by means of a propellant.
  • the antiperspirant cosmetic agents (M1) used according to the invention contain a propellant, this is preferably in a total amount of 1 to 98 wt .-%, preferably from 20 to 90 wt .-%, preferably from 30 to 85 wt .-%, in particular of 40 to 75 wt .-%, based on the total weight of the antiperspirant cosmetic agent (M1) included.
  • the total weight of the agent (M1) is the sum of the weight of all ingredients of the agent including the propellant.
  • Preferred propellants are propane, propene, n-butane, isobutane, isobutene, n-pentane, pentene, isopentane, isopentene, methane, ethane, dimethyl ether, nitrogen, air, oxygen, nitrous oxide, 1, 1, 1, 3-tetrafluoroethane, heptafluoro-n-propane, perfluoroethane, monochlorodifluoromethane, 1, 1 -difluoroethane, tetrafluoropropenes, both individually and in their mixtures. Also hydrophilic propellants, such.
  • hydrophilic gases can be used advantageously in the context of the present invention, when the proportion of hydrophilic gases is selected low and lipophilic propellant gas (eg., Propane / butane) is present in excess.
  • propellant gas eg., Propane / butane
  • propane, n-butane, isobutane and mixtures of these propellants propane, n-butane, isobutane and mixtures of these propellants. It has been found that the use of n-butane as the only propellant gas according to the invention can be particularly preferred.
  • the antiperspirant cosmetic agent (M1) used according to the invention is present as an oil-in-water emulsion.
  • the cosmetic agent according to the invention is preferably sprayed as a propellant-free pump spray or squeeze spray or applied as a roll-on.
  • the application of the antiperspirant cosmetic agent (M1) used according to the invention can be carried out by various methods.
  • the antiperspirant cosmetic agent (M1) used according to the invention is formulated as a spray application.
  • the spray application is carried out with a spray device which contains in a container a filling of the liquid, viscous-flowable, suspension-shaped or powdered antiperspirant cosmetic agent (M1) used according to the invention.
  • the filling may be under the pressure of a propellant, as described above (compressed gas cans, compressed gas packages, aerosol dispensers), or it may be a mechanically operated pump sprayer without propellant (pump sprays / squeeze bottle).
  • the atomization of the antiperspirant cosmetic agent (M1) used in the method according to the invention can be effected physically, mechanically or electromechanically, for example by piezoelectric effects or electrical pumps.
  • the at least one phosphonate compound in these sprayable, suspension-type cosmetic agents (M1) preferably has an average particle size D50 of from 1 to 300 ⁇ m, preferably from 5 to 125 ⁇ m, in particular from 10 to 100 ⁇ m.
  • the antiperspirant cosmetic agent (M1) used according to the invention can furthermore be preferably formulated as a stick, soft solid, cream, gel, roll-on, loose or compact powder.
  • the formulation of the antiperspirant cosmetic agents (M1) used in accordance with the invention in a particular administration form is preferably based on the requirements of the intended use.
  • the antiperspirant cosmetic agents (M1) used according to the invention can therefore be present in solid, semisolid, liquid, disperse, emulsified, suspended, gelatinous, multiphase or powdery form.
  • the term liquid also includes any types of solid dispersions in liquids.
  • multiphase antiperspirant cosmetic agents (M1) used according to the invention are understood to mean agents which have at least 2 different phases with a phase separation and in which the phases can be arranged horizontally, one above the other, or vertically, ie side by side.
  • the application can be done for example with a roller ball applicator, a pump sprayer or by means of a fixed pin.
  • the antiperspirant cosmetic agents (M1) used according to the invention are in the form of solid sticks, it is preferred if the at least one phosphonate compound has an average particle size D50 of from 1 to 300 ⁇ m, preferably from 5 to 125 ⁇ m, preferably from 10 to 100 m, in particular from 3 to 20 ⁇ , has.
  • the antiperspirant cosmetic agent (M1) is contained on and / or in a disposable substrate selected from the group of wipes, pads and bulbs.
  • a disposable substrate selected from the group of wipes, pads and bulbs.
  • wet wipes i. prefabricated for the user, preferably individually packaged, wet wipes, such as. B. from the field of glass cleaning or from the field of wet toilet paper are well known.
  • Such wet wipes which may advantageously also contain preservatives, are impregnated or applied with a sweat-inhibiting cosmetic agent (M1) used according to the invention and preferably individually packaged.
  • Preferred substrate materials are selected from porous sheet-like cloths.
  • wipes include wipes of woven and nonwoven synthetic and natural fibers, felt, paper or foam, such as hydrophilic polyurethane foam.
  • Deodorizing or antiperspirant substrates which are preferred according to the invention can be obtained by impregnation or impregnation or else by melting a sweat-inhibiting cosmetic agent (M1) used according to the invention onto a substrate.
  • Aluminum and / or aluminum zirconium salt 0-1.0 0-0.5 0-0.2 0
  • Cosmetic Carrier 2 Ad 100 Ad 100 Ad 100 Ad 100
  • Aluminum and / or aluminum zirconium salt 0-1.0 0-0.5 0-0.2 0
  • Aluminum and / or aluminum zirconium salt 0-1.0 0-0.5 0-0.2 0
  • Cosmetic Carrier 2 Ad 100 Ad 100 Ad 100 Ad 100
  • Aluminum and / or aluminum zirconium salt 0-1.0 0-0.5 0-0.2 0
  • Phosphonate compound a) of the formula (I) 5) 0.1-40 0.2-30.1 0-25 2.0-10
  • Aluminum and / or aluminum zirconium salt 0-1.0 0-0.5 0-0.2 0
  • Cosmetic Carrier 2 Ad 100 Ad 100 Ad 100 Ad 100
  • Phosphonate compound a) of the formula (I) 6) 0.1-40 0.2-30.1 0-25 2.0-10
  • Aluminum and / or aluminum zirconium salt 0-1.0 0-0.5 0-0.2 0
  • Phosphonate compound a) of the formula (I) 7) 0.1-40 0.2-30.1 0-25 2.0-10
  • Aluminum and / or aluminum zirconium salt 0-1.0 0-0.5 0-0.2 0
  • Cosmetic Carrier 2 Ad 100 Ad 100 Ad 100 Ad 100
  • Aluminum and / or aluminum zirconium salt 0-1.0 0-0.5 0-0.2 0
  • Aluminum and / or aluminum zirconium salt 0-1.0 0-0.5 0-0.2 0
  • Cosmetic Carrier 2 Ad 100 Ad 100 Ad 100 Ad 100
  • Aluminum and / or aluminum zirconium salt 0-1.0 0-0.5 0-0.2 0
  • Aluminum and / or aluminum zirconium salt 0-1.0 0-0.5 0-0.2 0
  • Emulsifier ° 0.1-15 0.5-10 1.0-8.0 2.0-6.0
  • Phosphonate compound contains at least one tertiary amine group and / or at least one secondary amine group and / or at least one hydroxyl group
  • R4 Cn-alkyl group
  • X + and Y + are each independently of one another hydrogen or Na + ,
  • Emulsifier selected from the group of ethoxylated C 12 -C 20 -alkanols with 10 to 30 moles of ethylene oxide per mole of alkanol, ethoxylated Cs-C24 carboxylic acids with 10 to 30 moles of ethylene oxide per mole of carboxylic acid, C 8 -C 22 alkyl mono- and oligoglycosides , ethoxylated sterols having a degree of ethoxylation of more than 5, partial esters of polyglycerols having 2 to 10 glycerol units and 1 to 4 saturated or unsaturated, linear or branched, optionally hydroxylated C8-C30 carboxylic acid residues, in particular ethoxylated C12-Cis alkanols having 10 to 30 Mol of ethylene oxide per mole of alkanol.
  • a further cosmetic agent (M2) which contains at least one antiperspirant active substance.
  • the means (M1) and (M2) can be applied in succession or simultaneously in any order. In this case, it may be provided, for example, first to apply the cosmetic agent (M1) and then the cosmetic product (M2). However, it is also possible first to apply the cosmetic product (M2) and then the cosmetic product (M1). In addition, the cosmetic agent (M1) and the cosmetic agent (M2) can be applied simultaneously.
  • the time span between the application of the two means (M1) and (M2) is preferably from 0 seconds (simultaneous application) to 24 hours.
  • a further cosmetic agent (M2) containing in a cosmetically acceptable carrier at least one antiperspirant aluminum and / or aluminum zirconium salt, is applied to the skin.
  • the cosmetic agent (M2) is different from the cosmetic agent (M1) and contains no phosphonate compounds with amine and / or hydroxyl groups. In this way, the antiperspirant effect of the method according to the invention can be further increased.
  • a further subject of the present invention is therefore a packaging unit (kit-of-parts) comprising - made up separately - a) at least one first container (C1) comprising a cosmetic agent (M1) comprising in a cosmetically acceptable carrier at least one phosphonate compound containing at least one tertiary amine group and / or at least one secondary amine group and / or at least one primary amine group and / or at least one hydroxyl group, and at most 1 wt .-%, based on the total weight of the cosmetic product (M1) antiperspirant aluminum and or aluminum-zirconium salts, and
  • the term "antiperspirant active ingredient” means active ingredients which reduce or reduce the perspiration of the eccrine sweat glands of the body
  • the antiperspirant active ingredient in the cosmetic agent (M2) is different from the phosphonate compounds contained in the agent (M1) Therefore, in the context of the present invention, the antiperspirant aluminum and / or aluminum zirconium salts mentioned in connection with the first subject of the invention are preferred as antiperspirant active ingredient in the cosmetic composition (M2 ) used.
  • Another object of the present invention is the use of at least one phosphonate compound which contains at least one tertiary amine group and / or at least one secondary amine group and / or at least one primary amine group and / or at least one hydroxyl group to reduce the transpiration of the body and / or to reduce the body odor caused by transpiration.
  • the amount of perspiration absorbed by the pads was determined gravimetrically, the composition was compared with the corresponding untreated spot on the back. From the gravimetric determination of the amount of sweat, the sweat reduction was determined, with all the values determined were statistically significant.
  • the phosphonate compound a) used in the following examples is preferably a compound of the formula (I) and / or of the formula (II), in particular aminotrimethylene phosphonate (ATMP).
  • Antiperspirant cosmetic agents used in the form of a solid stick according to the invention are used in the form of a solid stick according to the invention.
  • PPG-14 butyl ether 10.0 10.0 10.0 15.3 15.3 15.3 hardened castor oil eg Cutina HR 3.0 3.0 3.0 1, 5 1, 5 1, 5
  • Cyclomethicone (at least 95% by weight ad 100 ad 100 ad 100 ad 100 ad 100 ad 100 ad 100 cyclopentasiloxane)
  • Antiperspirant cosmetic agents used in the form of roll-ons according to the invention are used in the form of roll-ons according to the invention.
  • Antiperspirant cosmetic agents used according to the invention in the form of a solid water-in
  • Antiperspirant cosmetic agents used according to the invention (amounts in% by weight,
  • Example compositions 27-30 were filled into an aluminum epoxy spray can, optionally epoxy-phenolic coated, in a weight ratio of propellant (butane / propane / isobutane mixture) to suspension of 80:20, 85:15, 60:40 and 90:10, respectively.
  • propellant butane / propane / isobutane mixture
  • Antiperspirant cosmetic agents used according to the invention (amounts in% by weight,
  • Example compositions 31-33 were placed in an optionally epoxy-phenolic varnish-sprayed aluminum spray can at a weight ratio of propellant (butane / propane / isobutane mixture) to W / O emulsion of 80:20, 85:15, 60:40 and 90, respectively : 10 bottled.
  • propellant butane / propane / isobutane mixture
  • Antiperspirant cosmetic agents used in the form of O / W emulsions according to the invention are used in the form of O / W emulsions according to the invention.
  • Antiperspirant cosmetic agents used according to the invention (amounts in% by weight,
  • Example compositions 37-40 were placed in an optionally epoxy-phenolic varnish-sprayed aluminum spray can in a weight ratio of propellant (butane / propane / isobutane mixture) to W / O emulsion of 80:20, 85:15, 60:40 and 90, respectively : 10 bottled.
  • propellant butane / propane / isobutane mixture
  • Antiperspirant cosmetic agents used in the invention in the form of W / O emulsions
  • Antiperspirant cosmetic agents in the form of anhydrous used according to the invention are provided.
  • Antiperspirant cosmetic agents used in accordance with the invention in the form of PIT pump atomizers are used in accordance with the invention in the form of PIT pump atomizers
  • Antiperspirant cosmetic agents used in the form of a microemulsion according to the invention are used in the form of a microemulsion according to the invention.
  • Aerosil 972 SILICA DIMETHYL SILYLATE Evonik
  • Emulgade SE Glyceryl Stearate, Ceteareth-20, Ceteareth-12, BASF
  • Plantar ® 2000 DECYL GLUCOSIDE about 50% AS BASF

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)

Abstract

La présente invention concerne des procédés pour réduire la transpiration et/ou les odeurs corporelles produites par la transpiration, comprenant l'application sur la peau humaine de produits cosmétiques anti-transpirants (M1) comprenant un composé phosphonate avec des groupes amino et/ou hydroxyle, lesdits produits cosmétiques étant laissés sur le site d'application pendant au moins 1 heure. L'utilisation du ou des composés de type phosphate avec des groupes amino et/ou hydroxyle dans ces procédés permet d'obtenir un effet anti-transpirant ou une réduction des odeurs corporelles produites par la transpiration.
EP18722050.4A 2017-05-10 2018-05-04 Procédés pour réduire la transpiration et/ou les odeurs corporelles en utilisant des composés phosphonates avec des groupes amino et/ou hydroxyle Withdrawn EP3621584A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102017207927.4A DE102017207927A1 (de) 2017-05-10 2017-05-10 Verfahren zur Reduzierung des Schweißes und/oder Körpergeruchs unter Verwendung von Phosphonatverbindungen mit Amin- und/oder Hydroxylgruppen
PCT/EP2018/061565 WO2018206449A1 (fr) 2017-05-10 2018-05-04 Procédés pour réduire la transpiration et/ou les odeurs corporelles en utilisant des composés phosphonates avec des groupes amino et/ou hydroxyle

Publications (1)

Publication Number Publication Date
EP3621584A1 true EP3621584A1 (fr) 2020-03-18

Family

ID=62111093

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18722050.4A Withdrawn EP3621584A1 (fr) 2017-05-10 2018-05-04 Procédés pour réduire la transpiration et/ou les odeurs corporelles en utilisant des composés phosphonates avec des groupes amino et/ou hydroxyle

Country Status (4)

Country Link
US (1) US20200054541A1 (fr)
EP (1) EP3621584A1 (fr)
DE (1) DE102017207927A1 (fr)
WO (1) WO2018206449A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3258893B1 (fr) 2015-02-19 2020-09-02 Candesant Biomedical, Inc. Dispositifs médicaux de génération de chaleur
EP4378432A3 (fr) 2019-12-10 2024-07-31 Candesant Biomedical, Inc. Dispositif médical pour générer de la chaleur

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9513731D0 (en) * 1995-07-05 1995-09-06 Procter & Gamble Bactericidal compositions
GB0024689D0 (en) * 2000-10-09 2000-11-22 Unilever Plc Deodorant products
DE102012222692A1 (de) 2012-12-11 2013-09-05 Henkel Ag & Co. Kgaa Antibakterielles Kosmetikum
DE102014216917A1 (de) * 2014-08-26 2016-03-03 Henkel Ag & Co. Kgaa Schweißhemmende kosmetische Mittel mit speziellen Designproteinen, welche keine Halogenide und/oder Hydroxyhalogenide von Aluminium und/oder Zirconium enthalten

Also Published As

Publication number Publication date
US20200054541A1 (en) 2020-02-20
DE102017207927A1 (de) 2018-11-15
WO2018206449A1 (fr) 2018-11-15

Similar Documents

Publication Publication Date Title
WO2015085998A1 (fr) Produits cosmétiques antitranspirants sans composés contenant de l'aluminium
DE102015225958A1 (de) Kosmetische Mittel, enthaltend eine Kombination von mindestens zwei verschiedenen Wirkstoffen
EP3209387B1 (fr) Utilisation de chitosane dans compositions antitranspirantes qui ne contiennent pas les hydrochlorides ou chlorides d'aluminum ou et zirconium
EP3322397A1 (fr) Procédé de réduction de la transpiration et/ou des odeurs corporelles à l'aide de composés phosphate
EP3621584A1 (fr) Procédés pour réduire la transpiration et/ou les odeurs corporelles en utilisant des composés phosphonates avec des groupes amino et/ou hydroxyle
DE102015225876A1 (de) "Deodorantien, enthaltend spezielle kationische Morpholinoverbindungen in Kombination mit bestimmten Deowirkstoffen"
DE102017214252A1 (de) Verfahren zur Reduzierung des Schweißes und/oder Körpergeruchs
EP3250294B1 (fr) Antitranspirant contenant acide salicylique et des derives acides aminopolycarboxyliques
DE102015223846A1 (de) Verfahren zur Reduzierung des Schweißes und/oder Körpergeruchs unter Verwendung von speziellen Alkoholen
DE102016209760A1 (de) Verfahren zur Reduzierung des Schweißes und/oder Körpergeruchs unter Verwendung von speziellen anionischen Polymeren
DE102016218325A1 (de) Verfahren zur Reduzierung des Schweißes und/oder Körpergeruchs unter Verwendung von speziellen Säuren oder deren Derivaten
EP3166587A1 (fr) Produits cosmétiques anti-transpirants comprenant des protéines spéciales issues des légumineuses du genre glycine, lesquelles ne contiennent pas d'halogénures et/ou d'hydroxyhalogénures d'aluminium et/ou de zirconium
DE102015213345A1 (de) Verfahren zur Reduzierung des Schweißes und/oder Körpergeruchs unter Verwendung von Phosphatverbindungen und schweißhemmenden Aluminium- und/oder Aluminium-Zirkoniumsalzen
DE102014221910A1 (de) Verwendung eines aluminiumsalzfreien und/oder aluminium-zirconiumsalzfreien kosmetischen Mittels, enthaltend spezielle Aminosäurederivate sowie aus Eiern isolierte Proteine, zur Reduzierung und/oder Verhinderung von Schweiß
DE102014221802A1 (de) Verwendung von aluminiumsalzfreien und/oder aluminium-zirconiumsalzfreien kosmetischen Mittel, enthaltend spezielle Aminosäurederivate, zur Reduzierung und/oder Verhinderung von Schweiß
DE102014221912A1 (de) Verwendung eines aluminiumsalzfreien und/oder aluminium-zirconiumsalzfreien kosmetischen Mittels, enthaltend spezielle Aminosäurederivate sowie Proteine aus Malvengewächsen der Gattung Adansonia, zur Reduzierung und/oder Verhinderung von Schweiß
DE102014216914A1 (de) Schweißhemmende kosmetische Mittel mit speziellen, aus Pilzen isolierten Proteinen
DE102014221858A1 (de) Verwendung eines aluminiumsalzfreien und/oder aluminium-zirconiumsalzfreien kosmetischen Mittels, enthaltend spezielle Aminosäurederivate sowie Proteine aus Hülsenfrüchten der Gattung Glycine, zur Reduzierung und/oder Verhinderung von Schweiß
DE102014222021A1 (de) Verwendung eines aluminiumsalzfreien und/oder aluminium-zirconiumsalzfreien kosmetischen Mittels, enthaltend spezielle Aminosäurederivate sowie aus Pilzen isolierte Proteine, zur Reduzierung und/oder Verhinderung von Schweiß
DE102014221909A1 (de) Verwendung eines aluminiumsalzfreien und/oder aluminium-zirconiumsalzfreien kosmetischen Mittels, enthaltend spezielle Aminosäurederivate sowie aus Fischen oder Vögeln isolierte Proteine, zur Reduzierung und/oder Verhinderung von Schweiß
EP3166588A1 (fr) Agents cosmétiques anti-transpirants avec des protéines spéciales provenant de sécrétions animales, de sécrétions d'insectes ou de sécrétions humaines, qui ne contiennent pas d'halogénures et/ou d'hydroxyhalogénures d'aluminium et/ou de zirconium
DE102014221908A1 (de) Verwendung eines aluminiumsalzfreien und/oder aluminium-zirconiumsalzfreien kosmetischen Mittels, enthaltend spezielle Aminosäurederivate sowie Proteine aus menschlichen oder tierischen Quellen, zur Reduzierung und/oder Verhinderung von Schweiß
DE102014221913A1 (de) Verwendung eines aluminiumsalzfreien und/oder aluminium-zirconiumsalzfreien kosmetischen Mittels, enthaltend spezielle Aminosäurederivate sowie Proteine aus Kreuzblütengewächsen der Gattung Brassica, zur Reduzierung und/oder Verhinderung von Schweiß
DE102014216909A1 (de) Schweißhemmende kosmetische Mittel mit Proteinen aus Malvengewächsen der Gattung Adansonia
DE102014221911A1 (de) Verwendung eines aluminiumsalzfreien und/oder aluminium-zirconiumsalzfreien kosmetischen Mittels, enthaltend spezielle Aminosäurederivate sowie aus Bakterien isolierte Proteine, zur Reduzierung und/oder Verhinderung von Schweiß

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20191014

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20221201